Marker Therapeutics, Inc.

Marker Therapeutics, Inc. financial statements

Marker Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 3.55M10-K
Net income−USD 12.16M10-K
Cash and equivalentsUSD 16.07M10-Q

Marker Therapeutics, Inc. financials on 6ix · Marker Therapeutics, Inc. on 6ix